Astrocytic tumors are primary central nervous system tumors that either arises from astrocytes or appear similar to astrocytes on histology having arisen from precursor cells. They are the most common tumors arising from glial cells and can be broadly divided into three groups:
diffuse, adult-type
diffuse, pediatric type
circumscribed
These can further be divided into individual entities as described in the WHO classification of CNS tumors (5th edition, 2021), many of which are molecularly defined 3.
-
adult-type diffuse gliomas
astrocytoma, IDH-mutant: WHO CNS grade 2 to 4
glioblastoma, IDH-wildtype: WHO CNS grade 4
-
pediatric-type diffuse low-grade gliomas
angiocentric glioma: WHO CNS grade 1
diffuse astrocytoma, MYB- or MYBL1-altered: WHO CNS grade 1
diffuse low-grade glioma, MAPK pathway-altered: grade not assigned
-
pediatric-type diffuse high-grade gliomas
diffuse midline glioma, H3 K27-altered: WHO CNS grade 4
diffuse hemispheric glioma, H3 G34-mutant: WHO CNS grade 4
diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype: WHO CNS grade 4
infant-type hemispheric glioma: grade not assigned
-
circumscribed astrocytic gliomas
-
pilocytic astrocytoma: WHO CNS grade 1
pilomyxoid astrocytoma: WHO CNS grade 2
high-grade astrocytoma with piloid features: grade not assigned
pleomorphic xanthoastrocytoma: WHO CNS grade 2 or 3
subependymal giant cell astrocytoma: WHO CNS grade 1
chordoid glioma: WHO CNS grade 2
astroblastoma, MN1-altered: grade not assigned
-
Additionally, some tumors also contain astrocytic components, and it is often this component that dictates biological behavior. Examples include:
Most of these tumors have strikingly differing demographics, imaging appearances, treatment and prognosis and thus they are, along with spinal astrocytomas discussed separately.
Note: anaplastic astrocytoma, gliomatosis cerebri, fibrillary astrocytoma and protoplasmic astrocytoma, gemistocytic astrocytoma are no longer recognized as distinct entities in the WHO classification of CNS tumors.